In 2023, hospital discharges for malignant neoplasm of the prostate in Germany stood at approximately 114.75 thousand. From 2024 onwards, forecasts indicate a steady year-on-year increase in discharges, with a growth rate of about 1.62% in 2025, 1.58% in 2026, 1.54% in 2027, and 1.50% in 2028. The compound annual growth rate (CAGR) over these five years is approximately 1.56%.

Future trends to watch for:

The impact of early detection and advanced treatment methods on discharge rates.
Changes in demographic trends, such as the aging population.
Potential advancements in outpatient care and their effect on inpatient discharges.